CELU
Celularity Inc
Key Financials
Gross Profit
$6.8M
↑ 499.7%
Operating Income
$-38358000
↑ 80.1%
Net Income
$-57892000
↑ 70.5%
Total Assets
$132.7M
↓ 7.8%
EPS (Diluted)
$-2.64
↑ 76.0%
Revenue
$54.2M
↑ 138.1%
Cash & Equivalents
$738000.00
↑ 225.1%
Shareholders' Equity
$8.8M
↓ 78.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CELU |
| Company Name | Celularity Inc |
| CIK | 1752828 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (908) 768-2170 |